Skip to main content

Kura Oncology, Inc.

KURA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001422143

In the last 90 days, Kura Oncology, Inc. insiders filed 2 open-market purchases and 8 sales; 221 institutions reported holding it in 13F filings for Q2 2026, worth $953.1M in total; no superinvestor holds it.

13F holders, Q1 2023

Institutional positions in Kura Oncology, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
141
−1 vs. Q4 2022
Shares held
72.5M
+2.31M (+3.3%) vs. Q4 2022
Total value
$885.3M
+$15.0M (+1.7%) vs. Q4 2022
New holders
15
49 more added
Sold out
16
41 more reduced

Compare with Q4 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting KURA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2023: 141 institutions
Q1 2021: 171 institutionsQ2 2021: 171 institutionsQ3 2021: 152 institutionsQ4 2021: 151 institutionsQ1 2022: 152 institutionsQ2 2022: 148 institutionsQ3 2022: 148 institutionsQ4 2022: 142 institutionsQ1 2023: 141 institutionsQ2 2023: 148 institutionsQ3 2023: 133 institutionsQ4 2023: 141 institutionsQ1 2024: 165 institutionsQ2 2024: 174 institutionsQ3 2024: 179 institutionsQ4 2024: 185 institutionsQ1 2025: 183 institutionsQ2 2025: 182 institutionsQ3 2025: 200 institutionsQ4 2025: 215 institutionsQ1 2026: 222 institutionsQ2 2026: 221 institutions
Value heldQ1 2023: $885.3M
Q1 2021: $1.94BQ2 2021: $1.41BQ3 2021: $1.25BQ4 2021: $897.8MQ1 2022: $1.06BQ2 2022: $1.26BQ3 2022: $977.5MQ4 2022: $870.3MQ1 2023: $885.3MQ2 2023: $795.1MQ3 2023: $686.9MQ4 2023: $1.13BQ1 2024: $1.72BQ2 2024: $1.66BQ3 2024: $1.61BQ4 2024: $686.3MQ1 2025: $530.9MQ2 2025: $473.6MQ3 2025: $742.6MQ4 2025: $888.2MQ1 2026: $686.5MQ2 2026: $953.1M
Institutions holding KURA and their total value by quarter
QuarterHoldersValue
Q2 2026221$953.1M
Q1 2026222$686.5M
Q4 2025215$888.2M
Q3 2025200$742.6M
Q2 2025182$473.6M
Q1 2025183$530.9M
Q4 2024185$686.3M
Q3 2024179$1.61B
Q2 2024174$1.66B
Q1 2024165$1.72B
Q4 2023141$1.13B
Q3 2023133$686.9M
Q2 2023148$795.1M
Q1 2023141$885.3M
Q4 2022142$870.3M
Q3 2022148$977.5M
Q2 2022148$1.26B
Q1 2022152$1.06B
Q4 2021151$897.8M
Q3 2021152$1.25B
Q2 2021171$1.41B
Q1 2021171$1.94B

Institutions, Q1 2023

Shares, value and share of portfolio for each institution holding Kura Oncology, Inc.; share changes are against Q4 2022.

Institutions holding KURA in Q1 2023
InstitutionSharesValue% of portfolioChange in sharesAction
UBS Group AG214,140$2.62M0.00%−796−0.4%Reduced
Citigroup Inc220,988$2.70M0.00%+76,397+52.8%Added
Bank of New York Mellon Corp225,551$2.76M0.00%−5,114−2.2%Reduced
Barclays PLC227,115$2.78M0.00%+41,066+22.1%Added
Rafferty Asset Management, LLC274,554$3.36M0.02%−53,364−16.3%Reduced
Tekla Capital Management LLC283,281$3.46M0.13%00.0%Unchanged
Affinity Asset Advisors, LLC357,287$4.37M1.68%+88,540+32.9%Added
Alethea Capital Management, LLC363,773$4.45M4.70%00.0%Unchanged
Eagle Asset Management Inc375,493$4.59M0.03%−32,007−7.9%Reduced
Charles Schwab Investment Management Inc470,991$5.76M0.00%+1,959+0.4%Added
Woodline Partners LP489,532$5.99M0.08%+489,532New
Bank of America Corp506,204$6.19M0.00%+246,516+94.9%Added
JPMorgan Chase & Co513,222$6.28M0.00%−691−0.1%Reduced
Acuta Capital Partners, LLC565,257$6.91M5.38%+63,757+12.7%Added
Sphera Funds Management Ltd.603,287$7.38M1.60%+45,000+8.1%Added
Sofinnova Investments, Inc.616,169$7.54M0.51%+22,608+3.8%Added
Northern Trust Corp633,202$7.74M0.00%−128,032−16.8%Reduced
Nuveen Asset Management, LLC660,101$8.07M0.00%−35,560−5.1%Reduced
Candriam Luxembourg S.C.A.814,364$9.17M0.06%00.0%Unchanged
Goldman Sachs Group Inc1,086,800$13.3M0.00%−60,691−5.3%Reduced
Balyasny Asset Management LLC1,146,056$14.0M0.05%−1,152,963−50.2%Reduced
Assenagon Asset Management S.A.1,153,845$14.1M0.06%00.0%Unchanged
Franklin Resources Inc1,191,676$14.6M0.01%+126,416+11.9%Added
Commodore Capital LP1,204,958$14.7M2.24%+105,551+9.6%Added
Armistice Capital, LLC1,236,000$15.1M0.35%+164,000+15.3%Added
Geode Capital Management, LLC1,286,540$15.7M0.00%+57,110+4.6%Added
TCG Crossover Management, LLC1,423,642$17.4M3.39%00.0%Unchanged
Artal Group S.A.1,718,056$21.0M1.25%+18,056+1.1%Added
Dimensional Fund Advisors LP1,835,084$22.4M0.01%+133,912+7.9%Added
Foresite Capital Management IV, LLC1,849,947$22.6M11.74%00.0%Unchanged
Citadel Advisors LLC1,935,607$23.7M0.03%+1,211,847+167.4%Added
Deerfield Management Company, L.P. (Series C)2,383,000$29.1M0.65%00.0%Unchanged
Holocene Advisors, LP2,437,463$29.8M0.15%−101,142−4.0%Reduced
T. Rowe Price Investment Management, Inc.2,450,031$30.0M0.02%−218,533−8.2%Reduced
Avoro Capital Advisors LLC3,105,000$38.0M0.56%00.0%Unchanged
Vanguard Group Inc3,483,220$42.6M0.00%+78,051+2.3%Added
State Street Corp3,842,678$47.0M0.00%−603,749−13.6%Reduced
BlackRock Inc.5,369,307$65.7M0.00%+206,471+4.0%Added
Suvretta Capital Management, LLC6,573,335$80.4M3.88%+196,520+3.1%Added
EcoR1 Capital, LLC6,638,371$81.2M2.62%00.0%Unchanged
BVF Inc6,730,983$82.3M3.01%+2,930,000+77.1%Added
Victory Capital Management Inc0$00.00%−1,519,327−100.0%Sold out
AXA S.A.0$00.00%−296,184−100.0%Sold out
CI Private Wealth, LLC0$00.00%−38,500−100.0%Sold out
Altium Capital Management LP0$00.00%−28,198−100.0%Sold out
Ergoteles LLC0$00.00%−27,404−100.0%Sold out
Granite Point Capital Management, L.P.0$00.00%−25,000−100.0%Sold out
Qube Research & Technologies Ltd0$00.00%−18,887−100.0%Sold out
Sanders Morris Harris LLC0$00.00%−14,900−100.0%Sold out
DuPont Capital Management Corp0$00.00%−10,243−100.0%Sold out
Gyon Technologies Capital Management, LP0$00.00%−9,549−100.0%Sold out
Dark Forest Capital Management LP0$00.00%−970−100.0%Sold out
Belvedere Trading LLC0$00.00%−505−100.0%Sold out
Macquarie Group Ltd0$00.00%−469−100.0%Sold out
TCI Wealth Advisors, Inc.0$00.00%−318−100.0%Sold out
CWM, LLC0$00.00%−20−100.0%Sold out
Rockefeller Capital Management L.P.0$00.00%−26−100.0%Sold out